Literature DB >> 3183627

Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines.

K S Chen1, G V Quinnan.   

Abstract

Two split influenza virus vaccines administered intragastrically induced lower titres of haemagglutinin (HA)-specific antibodies in pulmonary secretions than whole virus vaccine or a third split virus vaccine. IgA antibody was the predominant HA-specific Ig class. HA-specific IgA titres decayed substantially within 2 weeks following booster immunization, but persisted for at least another 3.5 months. In contrast, HA-specific IgG was maintained at low titres throughout the 4 month study period. When the total vaccine antigenic mass was administered as one dose or as equally divided doses spread over several days, pulmonary antibody responses were comparable. Mice immunized intragastrically with whole virus vaccine were completely protected against intranasal challenge with a homologous virulent virus of the H3 subtype. Partial protection was obtained when the vaccine used for immunization was a distantly related, antigenically variant strain of the same subtype, but no protection was obtained with a monovalent vaccine of an influenza A subtype different to the challenge virus. These characteristics of the response to intragastric immunization against influenza are consistent with features of a useful vaccine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3183627     DOI: 10.1099/0022-1317-69-11-2779

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

Review 1.  Mucosal vaccines for the prevention of influenza.

Authors:  R L Clancy
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

2.  Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064.

Authors:  H Yasui; J Kiyoshima; T Hori; K Shida
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

3.  Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.

Authors:  Graeme E Price; Mark R Soboleski; Chia-Yun Lo; Julia A Misplon; Mary R Quirion; Katherine V Houser; Melissa B Pearce; Claudia Pappas; Terrence M Tumpey; Suzanne L Epstein
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

4.  Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model.

Authors:  Graeme E Price; Chia-Yun Lo; Julia A Misplon; Suzanne L Epstein
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

5.  Augmentation of anti-influenza virus hemagglutinin antibody production by Peyer's patch cells with Bifidobacterium breve YIT4064.

Authors:  H Yasui; N Nagaoka; K Hayakawa
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

6.  Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines.

Authors:  Saborni Chakraborty; Vamsee V A Mallajosyula; Troy C Sutton; Elaine W Lamirande; Ketaki Ganti; Kevin W Bock; Ian N Moore; Raghavan Varadarajan; Kanta Subbarao
Journal:  NPJ Vaccines       Date:  2017-12-15       Impact factor: 7.344

Review 7.  How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions.

Authors:  Elena Gianchecchi; Alessandro Manenti; Otfried Kistner; Claudia Trombetta; Ilaria Manini; Emanuele Montomoli
Journal:  Influenza Other Respir Viruses       Date:  2019-06-21       Impact factor: 4.380

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.